I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Houot, R.
232
results:
Search for persons
X
Format
Online (232)
Mediatypes
Articles (Online) (90)
Bookchapter (Online) (1)
OpenAccess-fulltext (141)
Languages
english (204)
french (21)
Sorted by: Relevance
Sorted by: Year
?
1
French early nationwide idecabtagene vicleucel chimeric ant..:
Ferment, B.
;
Lambert, J.
;
Caillot, D.
...
British Journal of Haematology. , 2024
Link:
https://doi.org/10.1111/..
?
2
Systemic relapses of primary CNS lymphomas (PCNSL): a LOC n..:
Dufour, J.
;
Choquet, S.
;
Hoang-Xuan, K.
...
Annals of Hematology. 102 (2023) 5 - p. 1159-1169 , 2023
Link:
https://doi.org/10.1007/..
?
3
Transfusion needs after CD19 CAR T‐cells for large B‐cell l..:
Vic, S.
;
Thibert, J.
;
Bachy, E.
...
Hematological Oncology. 41 (2023) S2 - p. 534-536 , 2023
Link:
https://doi.org/10.1002/..
?
4
VERY LONG‐TERM FOLLOW‐UP OF RITUXIMAB MAINTENANCE IN YOUNG ..:
Sarkozy, C.
;
Thieblemont, C.
;
Oberic, L.
...
Hematological Oncology. 41 (2023) S2 - p. 151-152 , 2023
Link:
https://doi.org/10.1002/..
?
5
Allogeneic transplantation in T‐cell lymphoma: Lessons from..:
Tournilhac, O.
;
Altmann, B.
;
Friedrichs, B.
...
Hematological Oncology. 41 (2023) S2 - p. 512-513 , 2023
Link:
https://doi.org/10.1002/..
?
6
Efficacy of anti‐PD1 therapy in relapsed or refractory NK/T..:
Marouf, A.
;
Chaubard, S.
;
Michot, J.
...
Hematological Oncology. 41 (2023) S2 - p. 502-503 , 2023
Link:
https://doi.org/10.1002/..
?
7
REMISSION AFTER CAR T‐CELLS: DO PATIENTS RECOVER A NORMAL L..:
Alya, P.
;
Colin, F.
;
Charton, E.
...
Hematological Oncology. 41 (2023) S2 - p. 786-787 , 2023
Link:
https://doi.org/10.1002/..
?
8
Valeur pronostique et prédictive de la TEP/TDM au [18F]FDG ..:
Marchal, E.
;
Novellox, E. Palard
;
Lhomme, F.
...
Médecine Nucléaire. 47 (2023) 2 - p. 47 , 2023
Link:
https://doi.org/10.1016/..
?
9
Baseline [18F]FDG PET features are associated with survival..:
Marchal, E.
;
Palard-Novello, X.
;
Lhomme, F.
...
European Journal of Nuclear Medicine and Molecular Imaging. 51 (2023) 2 - p. 481-489 , 2023
Link:
https://doi.org/10.1007/..
?
10
Remote monitoring of CAR T‐cell treated patients by a speci..:
Colin, F.
;
Bellec, A.
;
Le Bars, L.
...
Hematological Oncology. 41 (2023) S2 - p. 542-542 , 2023
Link:
https://doi.org/10.1002/..
?
11
3‐Year outcomes of adults with relapsed or refractory B‐cel..:
Shah, B. D.
;
Cassaday, R. D.
;
Park, J. H.
...
Hematological Oncology. 41 (2023) S2 - p. 520-521 , 2023
Link:
https://doi.org/10.1002/..
?
12
COMBINING CD19‐4‐1BBL (RO7227166) WITH GLOFITAMAB IS SAFE A..:
Hutchings, M.
;
Dickinson, M.
;
Carlo‐Stella, C.
...
Hematological Oncology. 41 (2023) S2 - p. 136-138 , 2023
Link:
https://doi.org/10.1002/..
?
13
RITUXIMAB AND IBRUTINIB COMBINATION IS SAFE AND EFFECTIVE I..:
Thieblemont, C.
;
Lamy, T.
;
Tani, M.
...
Hematological Oncology. 41 (2023) S2 - p. 104-106 , 2023
Link:
https://doi.org/10.1002/..
?
14
CAR‐T CELLS RADICALLY MODIFY THE MANAGEMENT OF RELAPSED/REF..:
Choquet, S.
;
Soussain, C.
;
Waultier‐Rascalou, A.
...
Hematological Oncology. 41 (2023) S2 - p. 43-44 , 2023
Link:
https://doi.org/10.1002/..
?
15
PROGNOSTIC SCORING SYSTEMS FOR SEVERE CRS AND ICANS AFTER A..:
Sesques, P.
;
Di blasi, R.
;
Legouill, S.
...
Hematological Oncology. 41 (2023) S2 - p. 202-204 , 2023
Link:
https://doi.org/10.1002/..
1-15